37th Skill Development Programme on Pharmacovigilance – Training Opportunity by IPC & PvPI

• About the Organizing Institution
• Programme Objectives
• Programme Structure and Learning Areas
• Key Training Areas
• Eligibility / Who Can Attend
• Educational Background (Examples)
• Programme Location and Registration Fee
• Application Process
• Frequently Asked Questions
• What is the Skill Development Programme on Pharmacovigilance?
• Who should attend this pharmacovigilance training?
• What topics are covered during the programme?
• Will participants receive a certificate?
• Where is the programme conducted?
• Programme Summary

Applications are invited for the 37th Skill Development Programme (SDP) on Pharmacovigilance organized by the National Coordination Centre – Pharmacovigilance Programme of India (NCC‑PvPI), Indian Pharmacopoeia Commission (IPC), Ministry of Health & Family Welfare, Government of India. The programme will be conducted offline from 15th to 19th June 2026 at NCC‑PvPI, IPC, Ghaziabad.

This intensive training programme is designed for pharmacy students, Pharm.D graduates, healthcare professionals, medical practitioners, nurses, academicians, and industry professionals who want to develop practical skills in pharmacovigilance, adverse drug reaction monitoring, drug safety reporting, and regulatory pharmacovigilance systems. The five‑day classroom programme provides hands‑on exposure to drug safety processes used in public health pharmacovigilance programmes.

The programme includes expert sessions, case studies, regulatory discussions, and practical demonstrations focused on adverse drug reaction reporting, pharmacovigilance systems, signal detection, and drug safety monitoring frameworks used in India and globally.

About the Organizing Institution

The Indian Pharmacopoeia Commission (IPC) is an autonomous institution under the Ministry of Health and Family Welfare, Government of India, responsible for setting standards for drugs in the country. IPC plays a crucial role in ensuring the quality, safety, and efficacy of medicines available in the Indian healthcare system.

The National Coordination Centre – Pharmacovigilance Programme of India (NCC‑PvPI) operates under IPC and serves as the central body responsible for monitoring and improving drug safety across India. PvPI collects and analyzes Adverse Drug Reaction (ADR) reports from hospitals, healthcare institutions, and pharmaceutical stakeholders to ensure safe use of medicines.

NCC‑PvPI is also recognized as a WHO Collaborating Centre for Pharmacovigilance in Public Health Programmes and Regulatory Services, which highlights its global significance in drug safety monitoring and pharmacovigilance training.

Through initiatives such as the Skill Development Programme, IPC aims to build capacity among healthcare professionals and strengthen the national pharmacovigilance ecosystem.

Programme Objectives

The Skill Development Programme on Pharmacovigilance is designed to provide participants with a strong understanding of drug safety systems and regulatory pharmacovigilance practices.

Key objectives of the training programme include:

• Understanding the fundamentals of pharmacovigilance and drug safety monitoring

• Training participants on adverse drug reaction (ADR) reporting systems

• Introducing regulatory pharmacovigilance frameworks followed by national and international agencies

• Providing practical knowledge on signal detection and safety data analysis

• Developing skills in pharmacovigilance documentation and regulatory reporting

• Enhancing understanding of the Pharmacovigilance Programme of India (PvPI)

• Promoting safe and rational use of medicines within the healthcare system

Participants will gain insights into real‑world pharmacovigilance processes used by regulatory authorities, hospitals, and pharmaceutical companies.

Programme Structure and Learning Areas

The five‑day classroom training programme includes interactive lectures, expert presentations, and case‑based learning sessions focusing on key pharmacovigilance topics.

Key Training Areas

• Introduction to Pharmacovigilance and Drug Safety Monitoring

• Adverse Drug Reaction (ADR) Reporting and Documentation

• Signal Detection and Risk Assessment

• Pharmacovigilance Regulatory Frameworks (India and Global)

• Role of Healthcare Professionals in Pharmacovigilance

• Pharmacovigilance Programme of India (PvPI) Operations

• Safety Monitoring of Medicines and Vaccines

• Case Processing and Safety Reporting Practices

• Public Health Pharmacovigilance Systems

Participants will also have opportunities to interact with pharmacovigilance experts and regulatory professionals involved in drug safety monitoring in India.

Eligibility / Who Can Attend

The Skill Development Programme is open to individuals from healthcare, academia, and the pharmaceutical industry who are interested in pharmacovigilance and drug safety science.

Eligible participants include:

• Pharmacy students and Pharm.D students

• B.Pharm and M.Pharm graduates

• MBBS and BDS students

• Nursing students and nurses

• Healthcare professionals working in pharmacovigilance

• Doctors and medical practitioners

• Academic faculty and researchers

• Pharmaceutical industry professionals

• Public health professionals

• Consumers and NGOs involved in healthcare awareness

Educational Background (Examples)

B.Pharm, M.Pharm, Pharm.D, BDS, MBBS, BSc Nursing, MSc Pharmacology, MSc Clinical Research, MSc Life Sciences, Pharmaceutical Sciences, Medical Sciences, Nursing, Public Health.

Participants interested in careers in pharmacovigilance, drug safety, clinical research, regulatory affairs, and pharmaceutical industry roles will benefit significantly from this programme.

Programme Location and Registration Fee

Location: NCC‑PvPI, Indian Pharmacopoeia Commission (IPC)

Address: Sector‑23, Raj Nagar, Ghaziabad – 201002, Uttar Pradesh, India

Mode: Offline (Classroom Training Programme)

Programme Dates: 15th – 19th June 2026

Registration Fee: INR 10,000 (including GST)

The registration fee covers training sessions and programme participation certification issued by the Indian Pharmacopoeia Commission.

Application Process

Candidates interested in attending the programme must complete the registration process through the official online form.

Apply Here:

https://docs.google.com/forms/d/e/1FAIpQLSegZ9V9TsR3S0HoQeU3oMf8jCdAShj1PIumouMqbireGJpaKw/viewform

Last Date to Apply: 8th June 2026

Applicants will be required to submit personal details, educational background, organization information, and payment confirmation during the registration process.

For any queries regarding the programme, participants may contact the organizing team at:

Phone: 0120‑2783400 (Ext. 374 / 378)

Email: training.nccpvpi-ipc@gov.in

Official Website: www.ipc.gov.in

Frequently Asked Questions

What is the Skill Development Programme on Pharmacovigilance?

The Skill Development Programme is a specialized training initiative conducted by the Indian Pharmacopoeia Commission to educate healthcare professionals about pharmacovigilance, drug safety monitoring, and adverse drug reaction reporting systems.

Who should attend this pharmacovigilance training?

Pharmacy students, Pharm.D graduates, doctors, nurses, pharmaceutical professionals, and researchers interested in drug safety and pharmacovigilance careers can attend the programme.

What topics are covered during the programme?

The training includes pharmacovigilance fundamentals, ADR reporting, signal detection, regulatory pharmacovigilance guidelines, and real‑world drug safety monitoring systems.

Will participants receive a certificate?

Yes. Participants who successfully complete the programme will receive a certificate from the Indian Pharmacopoeia Commission (IPC).

Where is the programme conducted?

The training will take place at the National Coordination Centre – Pharmacovigilance Programme of India (NCC‑PvPI), IPC, Ghaziabad, Uttar Pradesh.

Programme Summary